From the editor: selling the benefit of drug therapy.
Emory University School of Medicine, Atlanta, GA, USA. editorjcl@lipid.org
W Virgil
WV
Brown
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001055:Apolipoproteins B / Q000037:antagonists & inhibitors / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D008076:Cholesterol, HDL / Q000097:blood; D015243:Cholesterol, VLDL / Q000097:blood; D006801:Humans; D020319:Oligodeoxyribonucleotides, Antisense / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D001055:Apolipoproteins B; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D015243:Cholesterol, VLDL; D020319:Oligodeoxyribonucleotides, Antisense